UNIGE IRISmetadata only
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial
lingo-1, opicinumab, overall disability response score, relapsing multiple sclerosi, remyelination
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 264870
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.